drugset

drugset / Trial / NCT02422654

Taste Evaluation of Different Liquid Formulations With Eliglustat

NCT02422654 ↗

Phase 1 Completed 8 enrolled Genzyme, a Sanofi Company

RandomizedCrossoverSingle-blindTreatment

Summary

Primary Objective: The purpose of this study is to assess the palatability of eliglustat prototype liquid formulations in healthy subjects.

Timeline

Start: 2015-04
Primary completion: 2015-05
Completion: 2015-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eliglustat	Small molecule	5 ml	Oral

Indications